Aktie A3DFAX FORN EUROPAR
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen FORN EUROPAR

Aktien

A3DFAX

KYG3619H1020

FRBN

Realtime-Estimate Cboe BZX
Andere Börsenplätze
 18:33:17 17.05.2024 		% 5 Tage % 1. Jan.
13,66 USD -3,77 % Intraday Chart für FORN EUROPAR -1,46 % -37,68 %
2023 EnGene, Inc. hat die Übernahme von Forbion European Acquisition Corp. (NasdaqGM:FRBN) von einer Gruppe von Aktionären in einer Reverse-Merger-Transaktion abgeschlossen. CI
2023 Wall Street wird am Montag höher eröffnen, da die Anleger die Ergebnisse analysieren und die Fed-Sitzung abwarten MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.
Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Wall Street Set to Open Higher Friday; Core Inflation Rises 0.3% Matching Forecast
Top Premarket Decliners
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding
Forbion European Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding from Forbion Growth Sponsor Feac I B.V.
EnGene, Inc. and Forbion European Acquisition Corp. ("FEAC", Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies - Form 8-K
Forbion European Acquisition Corp. entered into a business combination agreement to acquire enGene, Inc from shareholders.
Forbion European Acquisition Corp. announced that it has received $56.891682 million in funding from a group of investors
Forbion European Acquisition Corp. announced that it received $56.891682 million in funding from enGene Holdings, and other investors
Forbion European Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Forbion European Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Forbion European Acquisition Corp. Auditor Raises 'Going Concern' Doubt
Forbion European Acquisition Corp. announced that it expects to receive $0.9 million in funding
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Certain Class B Ordinary Shares of Forbion European Acquisition Corp. are subject to a Lock-Up Agreement Ending on 8-JUN-2022.
Forbion European Acquisition Corp.(NasdaqGM:FRBN) added to NASDAQ Composite Index
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DFAX Aktie
  4. Nachrichten FORN EUROPAR
  5. Andere Sprachen